FX1
FX1 is a potent B cell lymphoma 6 (BCL6) inhibitor. FX1 displays 10-fold greater potency than endogenous corepressors and binds an essential region of the BCL6 lateral groove. FX1 disrupts formation of the BCL6 repression complex, reactivated BCL6 target genes, and mimics the phenotype of mice engineered to express BCL6 with corepressor binding site mutations.
Product Specifications
Shipping Conditions
gel pack
Storage Conditions
-20°C
Shelf Life
36 months
More Discoveries
Explore Other Products
Browse additional items from our catalog
K2377806 1.0 µg DNA
TKT sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)
Sign In for Pricing
View Details 
K2530208 1.0 µg DNA
TRNAV22 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)
Sign In for Pricing
View Details 
MBS7154103 Inquire
Rabbit anti-Escherichia coli (strain K12) STFE Polyclonal Antibody
Sign In for Pricing
View Details 